Article
Gamma-aminobutyric acid for delaying type 1 diabetes mellitus: an update
27 Jun 2024
Abstract excerpt
The current gold-standard management of hyperglycemia in individuals with type 1 diabetes mellitus (T1DM) is insulin therapy. However, this therapy is associated with a high incidence of complications, and delaying the onset of this disease produces a substantially positive impact on quality of life for individuals with a predisposition to T1DM, especially children. This review aimed to assess the use of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
